Medicine and Dentistry
Antidiabetic Activity
16%
Antidiabetic Agent
100%
Cell Compartment
16%
Cell Growth
16%
Cell Proliferation
16%
Cell Stress
16%
Cell Transdifferentiation
100%
Dapagliflozin
16%
Diabetes Mellitus
16%
Drug Therapy
100%
Gastric Inhibitory Polypeptide
16%
Glucagon Like Peptide 1
16%
Gut
16%
Hormone Release
16%
Hyperglycemia
16%
Incretin
100%
Insulin Dependent Diabetes Mellitus
100%
Liraglutide
16%
Pancreatic Islet
16%
Programmed Cell Death
16%
Secretion (Process)
16%
Sitagliptin
16%
Streptozocin
16%
Biochemistry, Genetics and Molecular Biology
Antidiabetic Activity
16%
Cell Growth
16%
Cell Proliferation
16%
Cell Stress
16%
Cyclic Adenosine Monophosphate
16%
Dapagliflozin
16%
Drug Therapy
100%
Ectopic Expression
16%
Gastric Inhibitory Polypeptide
16%
Glucagon-Like Peptide-1
16%
Hormone Release
16%
Hyperglycemia
16%
Incretin
100%
Liraglutide
16%
Programmed Cell Death
16%
Secretion (Process)
16%
Streptozotocin
16%
Transdifferentiation
100%
Pharmacology, Toxicology and Pharmaceutical Science
Antidiabetic Agent
100%
Dapagliflozin
16%
Diabetes Mellitus
16%
Gastric Inhibitory Polypeptide
16%
Glucagon-Like Peptide-1
16%
Hyperglycemia
16%
Incretin
100%
Insulin Dependent Diabetes Mellitus
100%
Liraglutide
16%
Pharmacotherapy
100%
Sitagliptin
16%
Streptozotocin
16%